In a recent study posted to the medRxiv preprint server, a team of researchers from Israel developed and validated novel reverse transcriptase - quantitative polymerase chain reaction (RT-qPCR) assays. The new assays enable the rapid and high throughput identification and differentiation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1 and BA.2 variants.
As The Epoch Times and other media outlets reported yesterday, a shocking new study conducted at Lund University in Sweden has confirmed that mRNA nanoparticles from Pfizer's covid-19 [.]